Immucell Corp /De/ (ICCC) Stock Price & Analysis
Immucell Corp /De/ (ICCC) fell 1.00% to USD 9.9 as of September 8, 2026 at 09:05 UTC, according to Nexqual real-time market data.
ICCC last closed at USD 9.9; the session ranged USD 9.8–9.97 on volume of 11,696 shares. Market capitalization is —, with a 52-week range of USD 4.52–12.1 (NCM). Source: Nexqual, September 8, 2026 at 09:05 UTC.
Key Statistics (as of September 8, 2026 at 09:05 UTC)
| Price | USD 9.9 |
|---|---|
| Change | ▼ 1.00% (down) |
| Previous Close | USD 9.9 |
| Open | USD 9.9 |
| Day Range | USD 9.8 – 9.97 |
| 52-Week Range | USD 4.52 – 12.1 |
| Volume | 11,696 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (ICCC)
Nexqual's technical model rates ICCC "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 09:05 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 37.58 (neutral) |
| vs SMA50 | Below (USD 10.58) |
| MACD | -0.2 (negative) |
From Immucell Corp /De/'s Latest SEC 10-K Filing (filed 2026-03-30)
Partnerships
- The Company markets its products through its commercial sales team, in partnership with national and regional animal‑health distributors.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IRIX | IRIDEX Corporation | USD 0.7 | ▼ 2.78% |
| NAII | Natural Alternatives Internatio | USD 2.08 | ▼ 1.89% |
| CSBR | Champions Oncology, Inc. | USD 5.22 | ▲ 1.36% |
| CYAN | Cyanotech Corp. | USD 0.49 | ▼ 3.92% |
| INTG | The Intergroup Corporation | USD 36.17 | ▲ 3.7% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:05 UTC. This page is informational and not investment advice.